Haber E
Circulation. 1976 Dec;54(6):849-61. doi: 10.1161/01.cir.54.6.849.
Recently, the availability of a number of specific inhibitors of the renin-angiotensin system has made it possible to address certain critical questions concerning the role of angiotensin II in physiologic homeostasis and in a number of pathologic states. These studies indicate that angiotensin II does not have an obligatory role in blood pressure maintenance in the normal, sodium replete individual, but it is essential following sodium depletion. The role of angiotensin II in feedback control of renin secretion is confirmed as is its importance in aldosterone stimulation both in relation to posture and sodium depletion. Angiotensin II is responsible for the initial pressor response of experimental renovascular hypertension and appears to be important in the initiation of chronic renovascular hypertension. Converting enzyme blockers and competitive inhibitors of angiotensin II are helpful in the diagnosis of clinical renovascular hypertension and in the identification of renin dependent hypertensives. Homeostatic mechanisms leading to maintenance of blood pressure and accumulation of edema in experimental congestive heart failure appear to be dependent on angiotensin II.
最近,多种肾素 - 血管紧张素系统特异性抑制剂的出现,使得解决一些关于血管紧张素II在生理稳态及多种病理状态中作用的关键问题成为可能。这些研究表明,血管紧张素II在正常、钠充足个体的血压维持中并非起必不可少的作用,但在钠耗竭后却是至关重要的。血管紧张素II在肾素分泌的反馈控制中的作用得到了证实,其在醛固酮刺激中对于体位和钠耗竭的重要性也得到了证实。血管紧张素II是实验性肾血管性高血压初始升压反应的原因,并且在慢性肾血管性高血压的发病中似乎也很重要。血管紧张素转换酶阻滞剂和血管紧张素II竞争性抑制剂有助于临床肾血管性高血压的诊断以及肾素依赖性高血压患者的识别。在实验性充血性心力衰竭中,导致血压维持和水肿蓄积的稳态机制似乎依赖于血管紧张素II。